PharVision Advisers »

Fulcrum Therapeutics shares owned by PharVision Advisers

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $220k 24k 9.20

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics